Syndeio Biosciences, Inc

This study tested an experimental drug called AGN-241751 in 226 adults with major depressive disorder. The goal was to see if it safely reduces depression symptoms better than a placebo. Participants received either the drug or a placebo, and their depression levels were measured…

This study tested whether a new oral drug called zelquistinel can quickly improve mood in adults with major depression. 251 participants received either the drug or a placebo, and researchers measured depression symptoms using a standard rating scale. The main goal was to see if …

This early-stage study tested a single dose of the experimental drug AGN-241751 (zelquistinel) in 68 healthy adults to see if it is safe and how the body processes it. The main goal was to check for side effects, and the study also measured drug levels in the blood. This trial di…